Ascentage Pharma Group International saw the highest growth of 1.99% in patent filings in June and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Ascentage Pharma Group International’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Ascentage Pharma Group International has been focused on protecting inventions in European Patent Office(EPO) with four publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 40% of filings. The European Patent Office(EPO), United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Ascentage Pharma Group International is filings its patents. Among the top granted patent authorities, Ascentage Pharma Group International has 100% of its grants in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Ascentage Pharma Group International
Patents related to rare diseases and climate change lead Ascentage Pharma Group International's portfolio
Ascentage Pharma Group International has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Leukemia related patents lead Ascentage Pharma Group International portfolio followed by multiple myeloma (kahler disease), and manufacturing/industrial
Ascentage Pharma Group International has highest number of patents in leukemia followed by multiple myeloma (kahler disease), manufacturing/industrial, breast cancer, and cervical cancer.
For comprehensive analysis of Ascentage Pharma Group International's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
